[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware
(State or other jurisdiction of
incorporation or organization) |
51-0263969
(I.R.S. Employer Identification No.)
|
6901 Professional Pkwy. East, Suite 200
Sarasota, Florida (Address of principal executive offices) |
34240
(Zip Code)
|
(941) 556-2601
(Registrant's telephone number, including area code)
|
þ Large accelerated filer
|
¨ Accelerated filer
|
¨ Non-accelerated filer (do not check if smaller reporting company)
|
¨ Smaller reporting company
|
|
|
Page
|
PART I.
|
FINANCIAL INFORMATION
|
|
Item 1.
|
Financial Statements (unaudited):
|
|
|
Condensed Consolidated Statements of Earnings
|
3
|
|
Condensed Consolidated Statements of Comprehensive Income
|
4
|
|
Condensed Consolidated Balance Sheets
|
5
|
|
Condensed Consolidated Statements of Cash Flows
|
6
|
|
Condensed Consolidated Statement of Changes in Stockholders' Equity
|
7
|
|
Notes to Condensed Consolidated Financial Statements
|
8
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
15
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
22
|
Item 4.
|
Controls and Procedures
|
23
|
PART II.
|
OTHER INFORMATION
|
|
Item 1.
|
Legal Proceedings
|
23
|
Item 1A.
|
Risk Factors
|
23
|
Item 6.
|
Exhibits
|
24
|
|
Signatures
|
25
|
PART I. | FINANCIAL INFORMATION |
|
|
Three months ended June 30,
|
|
Six months ended June 30,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
784,010
|
|
$
|
724,872
|
|
$
|
1,521,145
|
|
$
|
1,435,938
|
|
Cost of sales
|
|
|
338,503
|
|
|
327,264
|
|
|
654,062
|
|
|
647,137
|
|
Gross profit
|
|
|
445,507
|
|
|
397,608
|
|
|
867,083
|
|
|
788,801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
265,761
|
|
|
218,824
|
|
|
502,160
|
|
|
439,713
|
|
Income from operations
|
|
|
179,746
|
|
|
178,784
|
|
|
364,923
|
|
|
349,088
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
22,361
|
|
|
15,077
|
|
|
43,219
|
|
|
30,560
|
|
Other income/(expense), net
|
|
|
2,536
|
|
|
(574
|
)
|
|
44
|
|
|
(1,064
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings before income taxes
|
|
|
159,921
|
|
|
163,133
|
|
|
321,748
|
|
|
317,464
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
|
48,568
|
|
|
48,320
|
|
|
85,481
|
|
|
94,342
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
111,353
|
|
$
|
114,813
|
|
$
|
236,267
|
|
$
|
223,122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.12
|
|
$
|
1.18
|
|
$
|
2.39
|
|
$
|
2.29
|
|
Diluted
|
|
|
1.11
|
|
|
1.15
|
|
|
2.36
|
|
|
2.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
99,089
|
|
|
97,460
|
|
|
98,983
|
|
|
97,249
|
|
Diluted
|
|
|
100,162
|
|
|
99,619
|
|
|
100,071
|
|
|
99,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.1650
|
|
$
|
0.1375
|
|
$
|
0.3300
|
|
$
|
0.2750
|
|
|
|
Three months ended June 30,
|
|
Six months ended June 30,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
111,353
|
|
$
|
114,813
|
|
$
|
236,267
|
|
$
|
223,122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income/(loss), net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
|
|
(3,632
|
)
|
|
(33,208
|
)
|
|
(42,121
|
)
|
|
(14,047
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income/(loss), net of tax
|
|
|
(3,632
|
)
|
|
(33,208
|
)
|
|
(42,121
|
)
|
|
(14,047
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
107,721
|
|
$
|
81,605
|
|
$
|
194,146
|
|
$
|
209,075
|
|
|
|
June 30, 2013
|
|
December 31, 2012
|
|
||
ASSETS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
374,571
|
|
$
|
370,590
|
|
Accounts receivable, net
|
|
|
547,572
|
|
|
526,408
|
|
Inventories, net
|
|
|
197,458
|
|
|
190,867
|
|
Deferred taxes
|
|
|
58,582
|
|
|
41,992
|
|
Unbilled receivables
|
|
|
84,319
|
|
|
72,193
|
|
Other current assets
|
|
|
65,633
|
|
|
43,492
|
|
Total current assets
|
|
|
1,328,135
|
|
|
1,245,542
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
115,677
|
|
|
110,397
|
|
Goodwill
|
|
|
4,521,774
|
|
|
3,868,857
|
|
Other intangible assets, net
|
|
|
2,084,677
|
|
|
1,698,867
|
|
Deferred taxes
|
|
|
86,579
|
|
|
78,644
|
|
Other assets
|
|
|
76,900
|
|
|
68,797
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
8,213,742
|
|
$
|
7,071,104
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
139,296
|
|
$
|
138,340
|
|
Accrued compensation
|
|
|
83,862
|
|
|
110,724
|
|
Deferred revenue
|
|
|
209,249
|
|
|
185,912
|
|
Other accrued liabilities
|
|
|
171,050
|
|
|
128,351
|
|
Deferred taxes
|
|
|
10,595
|
|
|
3,868
|
|
Current portion of long-term debt, net
|
|
|
512,799
|
|
|
519,015
|
|
Total current liabilities
|
|
|
1,126,851
|
|
|
1,086,210
|
|
|
|
|
|
|
|
|
|
Long-term debt, net of current portion
|
|
|
2,245,424
|
|
|
1,503,107
|
|
Deferred taxes
|
|
|
856,551
|
|
|
707,278
|
|
Other liabilities
|
|
|
95,368
|
|
|
86,783
|
|
Total liabilities
|
|
|
4,324,194
|
|
|
3,383,378
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 10)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
1,012
|
|
|
1,006
|
|
Additional paid-in capital
|
|
|
1,198,269
|
|
|
1,158,001
|
|
Retained earnings
|
|
|
2,693,421
|
|
|
2,489,858
|
|
Accumulated other comprehensive earnings
|
|
|
16,416
|
|
|
58,537
|
|
Treasury stock
|
|
|
(19,570
|
)
|
|
(19,676
|
)
|
Total stockholders' equity
|
|
|
3,889,548
|
|
|
3,687,726
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
8,213,742
|
|
$
|
7,071,104
|
|
|
|
Six months ended June 30,
|
|
||||
|
|
2013
|
|
2012
|
|
||
Cash flows from operating activities:
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
236,267
|
|
$
|
223,122
|
|
Adjustments to reconcile net earnings to cash flows from operating activities:
|
|
|
|
|
|
|
|
Depreciation and amortization of property, plant and equipment
|
|
|
18,742
|
|
|
18,950
|
|
Amortization of intangible assets
|
|
|
71,794
|
|
|
52,289
|
|
Amortization of deferred financing costs
|
|
|
1,802
|
|
|
1,181
|
|
Non-cash stock compensation
|
|
|
26,284
|
|
|
19,704
|
|
Changes in operating assets and liabilities, net of acquired businesses:
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
10,636
|
|
|
(2,321
|
)
|
Unbilled receivables
|
|
|
(12,483
|
)
|
|
(10,244
|
)
|
Inventories
|
|
|
(10,362
|
)
|
|
(5,452
|
)
|
Accounts payable and accrued liabilities
|
|
|
(9,091
|
)
|
|
(20,371
|
)
|
Income taxes payable
|
|
|
(17,925
|
)
|
|
(18,615
|
)
|
Other, net
|
|
|
(4,657
|
)
|
|
2,540
|
|
Cash provided by operating activities
|
|
|
311,007
|
|
|
260,783
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
Acquisitions of businesses, net of cash acquired
|
|
|
(1,007,513
|
)
|
|
(36,872
|
)
|
Capital expenditures
|
|
|
(21,889
|
)
|
|
(20,532
|
)
|
Proceeds from sale of assets
|
|
|
1,349
|
|
|
1,018
|
|
Other, net
|
|
|
(35
|
)
|
|
(474
|
)
|
Cash used in investing activities
|
|
|
(1,028,088
|
)
|
|
(56,860
|
)
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
Proceeds from senior notes
|
|
|
800,000
|
|
|
-
|
|
Payments under revolving line of credit, net
|
|
|
(58,000
|
)
|
|
-
|
|
Principal payments on convertible notes
|
|
|
(1,671
|
)
|
|
(13,215
|
)
|
Cash premiums paid on convertible note conversions
|
|
|
(4,040
|
)
|
|
(19,149
|
)
|
Debt issuance costs
|
|
|
(7,517
|
)
|
|
-
|
|
Cash dividends to stockholders
|
|
|
(16,338
|
)
|
|
(26,673
|
)
|
Proceeds from stock based compensation, net
|
|
|
10,998
|
|
|
28,314
|
|
Stock award tax excess windfall benefit
|
|
|
5,654
|
|
|
11,070
|
|
Treasury stock sales
|
|
|
1,250
|
|
|
1,123
|
|
Other
|
|
|
576
|
|
|
(1,107
|
)
|
Cash provided by/(used in) financing activities
|
|
|
730,912
|
|
|
(19,637
|
)
|
|
|
|
|
|
|
|
|
Effect of foreign currency exchange rate changes on cash
|
|
|
(9,850
|
)
|
|
(3,489
|
)
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
3,981
|
|
|
180,797
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
|
|
370,590
|
|
|
338,101
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period
|
|
$
|
374,571
|
|
$
|
518,898
|
|
|
|
Common
stock |
|
Additional paid-in capital
|
|
Retained
earnings
|
|
Accumulated other comprehensive earnings
|
|
Treasury
stock
|
|
Total
|
|
||||||
Balances at December 31, 2012
|
|
$
|
1,006
|
|
$
|
1,158,001
|
|
$
|
2,489,858
|
|
$
|
58,537
|
|
$
|
(19,676
|
)
|
$
|
3,687,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
|
-
|
|
|
-
|
|
|
236,267
|
|
|
-
|
|
|
-
|
|
|
236,267
|
|
Stock option exercises
|
|
|
3
|
|
|
14,408
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
14,411
|
|
Treasury stock sold
|
|
|
-
|
|
|
1,144
|
|
|
-
|
|
|
-
|
|
|
106
|
|
|
1,250
|
|
Currency translation adjustments, net of $2,707 tax
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(42,121
|
)
|
|
-
|
|
|
(42,121
|
)
|
Stock based compensation
|
|
|
-
|
|
|
26,289
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
26,289
|
|
Restricted stock activity
|
|
|
3
|
|
|
(3,402
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(3,399
|
)
|
Stock option tax benefit, net of shortfalls
|
|
|
-
|
|
|
5,557
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
5,557
|
|
Conversion of senior subordinated convertible notes, net of $312 tax
|
|
|
-
|
|
|
(3,728
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(3,728
|
)
|
Dividends declared
|
|
|
-
|
|
|
-
|
|
|
(32,704
|
)
|
|
-
|
|
|
-
|
|
|
(32,704
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at June 30, 2013
|
|
$
|
1,012
|
|
$
|
1,198,269
|
|
$
|
2,693,421
|
|
$
|
16,416
|
|
$
|
(19,570
|
)
|
$
|
3,889,548
|
|
1.
|
Basis of Presentation
|
2.
|
Recent Accounting Pronouncements
|
3.
|
Earnings Per Share
|
|
Three months ended June 30,
|
Six months ended June 30,
|
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
Basic shares outstanding
|
99,089
|
97,460
|
98,983
|
97,249
|
||||||||||||
Effect of potential common stock:
|
||||||||||||||||
Common stock awards
|
882
|
1,129
|
884
|
1,172
|
||||||||||||
Senior subordinated convertible notes
|
191
|
1,030
|
204
|
1,079
|
||||||||||||
Diluted shares outstanding
|
100,162
|
99,619
|
100,071
|
99,500
|
4.
|
Business Acquisitions
|
Current assets
|
$
|
59,813
|
||
Identifiable intangibles
|
465,500
|
|||
Goodwill
|
679,999
|
|||
Other assets
|
5,798
|
|||
Total assets acquired
|
1,211,110
|
|||
Current liabilities
|
(24,717
|
)
|
||
Long-term deferred tax liability
|
(164,319
|
)
|
||
Other liabilities
|
(6,524
|
)
|
||
Net assets acquired
|
$
|
1,015,550
|
5.
|
Stock Based Compensation
|
|
Three months ended
June 30, |
Six months ended
June 30, |
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
Stock based compensation
|
$
|
13,307
|
$
|
9,749
|
$
|
26,284
|
$
|
19,704
|
||||||||
Tax effect recognized in net income
|
4,658
|
3,412
|
9,199
|
6,896
|
||||||||||||
Windfall tax benefit/(shortfall), net
|
1,245
|
3,551
|
5,557
|
10,966
|
|
Six months ended June 30,
|
||
|
2013
|
|
2012
|
Fair value per share ($)
|
36.55
|
|
29.39
|
Risk-free interest rate (%)
|
0.78
|
|
0.82
|
Expected option life (years)
|
5.19
|
|
5.22
|
Expected volatility (%)
|
36.22
|
|
36.55
|
Expected dividend yield (%)
|
0.57
|
|
0.59
|
6.
|
Inventories
|
|
|
June 30,
2013 |
|
December 31,
2012 |
|
||
|
|
(in thousands)
|
|
||||
Raw materials and supplies
|
|
$
|
123,437
|
|
$
|
121,573
|
|
Work in process
|
|
|
33,648
|
|
|
29,725
|
|
Finished products
|
|
|
84,639
|
|
|
81,536
|
|
Inventory reserves
|
|
|
(44,266
|
)
|
|
(41,967
|
)
|
|
|
$
|
197,458
|
|
$
|
190,867
|
|
7.
|
Goodwill and Other Intangible Assets
|
|
Industrial Technology
|
|
Energy Systems & Controls
|
|
Medical & Scientific Imaging
|
|
RF Technology
|
|
Total
|
|
|||||
Balances at December 31, 2012
|
$
|
421,755
|
|
$
|
404,057
|
|
$
|
1,772,402
|
|
$
|
1,270,643
|
|
$
|
3,868,857
|
|
Additions
|
|
-
|
|
|
-
|
|
|
679,999
|
|
|
-
|
|
|
679,999
|
|
Other
|
|
-
|
|
|
-
|
|
|
(3,793
|
)
|
|
445
|
|
|
(3,348
|
)
|
Currency translation adjustments
|
|
(4,019
|
)
|
|
(2,400
|
)
|
|
(11,647
|
)
|
|
(5,668
|
)
|
|
(23,734
|
)
|
Balances at June 30, 2013
|
$
|
417,736
|
|
$
|
401,657
|
|
$
|
2,436,961
|
|
$
|
1,265,420
|
|
$
|
4,521,774
|
|
|
|
Cost
|
|
Accumulated
amortization |
|
Net book
value |
|
|||
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Customer related intangibles
|
|
$
|
1,509,339
|
|
$
|
(379,535
|
)
|
$
|
1,129,804
|
|
Unpatented technology
|
|
|
198,609
|
|
|
(97,487
|
)
|
|
101,122
|
|
Software
|
|
|
160,520
|
|
|
(44,256
|
)
|
|
116,264
|
|
Patents and other protective rights
|
|
|
40,399
|
|
|
(20,312
|
)
|
|
20,087
|
|
Trade secrets
|
|
|
1,500
|
|
|
(1,500
|
)
|
|
-
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
331,590
|
|
|
-
|
|
|
331,590
|
|
Balances at December 31, 2012
|
|
$
|
2,241,957
|
|
$
|
(543,090
|
)
|
$
|
1,698,867
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Customer related intangibles
|
|
$
|
1,934,311
|
|
$
|
(426,269
|
)
|
$
|
1,508,042
|
|
Unpatented technology
|
|
|
210,943
|
|
|
(109,356
|
)
|
|
101,587
|
|
Software
|
|
|
160,245
|
|
|
(51,248
|
)
|
|
108,997
|
|
Patents and other protective rights
|
|
|
30,150
|
|
|
(21,420
|
)
|
|
8,730
|
|
Trade secrets
|
|
|
1,500
|
|
|
(1,500
|
)
|
|
-
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
357,321
|
|
|
-
|
|
|
357,321
|
|
Balances at June 30, 2013
|
|
$
|
2,694,470
|
|
$
|
(609,793
|
)
|
$
|
2,084,677
|
|
8.
|
Debt
|
9.
|
Fair Value of Financial Instruments
|
$500 million senior notes due 2013
|
$
|
503
|
||
$400 million senior notes due 2017
|
394
|
|||
$800 million senior notes due 2018
|
786
|
|||
$500 million senior notes due 2019
|
582
|
|||
$500 million senior notes due 2022
|
477
|
10.
|
Contingencies
|
Balance at December 31, 2012
|
|
$
|
9,755
|
|
Additions charged to costs and expenses*
|
|
|
14,935
|
|
Deductions
|
|
|
(5,900
|
)
|
Other
|
|
|
(243
|
)
|
Balance at June 30, 2013
|
|
$
|
18,547
|
|
11.
|
Business Segments
|
|
Three months ended
June 30, |
|
|
Six months ended
June 30, |
|
|
|||||||||
|
2013
|
|
2012
|
Change
|
|
2013
|
|
2012
|
Change
|
|
|||||
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
197,543
|
|
$
|
203,944
|
(3.1
|
)%
|
$
|
379,782
|
|
$
|
399,080
|
(4.8
|
)%
|
|
Energy Systems & Controls
|
|
155,331
|
|
|
154,737
|
0.4
|
|
|
300,973
|
|
|
303,339
|
(0.8
|
)
|
|
Medical & Scientific Imaging
|
|
207,957
|
|
|
150,921
|
37.8
|
|
|
408,401
|
|
|
313,732
|
30.2
|
|
|
RF Technology
|
|
223,179
|
|
|
215,270
|
3.7
|
|
|
431,989
|
|
|
419,787
|
2.9
|
|
|
Total
|
$
|
784,010
|
|
$
|
724,872
|
8.2
|
%
|
$
|
1,521,145
|
|
$
|
1,435,938
|
5.9
|
%
|
|
Gross profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
101,844
|
|
$
|
102,770
|
(0.9
|
)%
|
$
|
195,155
|
|
$
|
201,433
|
(3.1
|
)%
|
|
Energy Systems & Controls
|
|
87,421
|
|
|
86,135
|
1.5
|
|
|
168,327
|
|
|
166,543
|
1.1
|
|
|
Medical & Scientific Imaging
|
|
138,416
|
|
|
96,212
|
43.9
|
|
|
273,285
|
|
|
202,398
|
35.0
|
|
|
RF Technology
|
|
117,826
|
|
|
112,491
|
4.7
|
|
|
230,316
|
|
|
218,427
|
5.4
|
|
|
Total
|
$
|
445,507
|
|
$
|
397,608
|
12.0
|
%
|
$
|
867,083
|
|
$
|
788,801
|
9.9
|
%
|
|
Operating profit*:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
50,580
|
|
$
|
62,076
|
(18.5
|
)%
|
$
|
103,525
|
|
$
|
119,583
|
(13.4
|
)%
|
|
Energy Systems & Controls
|
|
41,634
|
|
|
40,202
|
3.6
|
|
|
77,356
|
|
|
75,859
|
2.0
|
|
|
Medical & Scientific Imaging
|
|
47,537
|
|
|
35,679
|
33.2
|
|
|
107,465
|
|
|
79,041
|
36.0
|
|
|
RF Technology
|
|
60,729
|
|
|
58,161
|
4.4
|
|
|
117,359
|
|
|
108,514
|
8.2
|
|
|
Total
|
$
|
200,480
|
|
$
|
196,118
|
2.2
|
%
|
$
|
405,705
|
|
$
|
382,997
|
5.9
|
%
|
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
$
|
46,565
|
|
$
|
43,096
|
8.0
|
%
|
|
|
|
|
|
|
|
|
Energy Systems & Controls
|
|
19,361
|
|
|
18,892
|
2.5
|
|
|
|
|
|
|
|
|
|
Medical & Scientific Imaging
|
|
42,926
|
|
|
44,314
|
(3.1
|
)
|
|
|
|
|
|
|
|
|
RF Technology
|
|
28,298
|
|
|
28,639
|
(1.2
|
)
|
|
|
|
|
|
|
|
|
Total
|
$
|
137,150
|
|
$
|
134,941
|
1.6
|
%
|
|
|
|
|
|
|
|
·
|
general economic conditions;
|
·
|
difficulty making acquisitions and successfully integrating acquired businesses;
|
·
|
any unforeseen liabilities associated with future acquisitions;
|
·
|
limitations on our business imposed by our indebtedness;
|
·
|
unfavorable changes in foreign exchange rates;
|
·
|
difficulties associated with exports;
|
·
|
risks and costs associated with our international sales and operations;
|
·
|
increased directors' and officers' liability and other insurance costs;
|
·
|
risk of rising interest rates;
|
·
|
product liability and insurance risks;
|
·
|
increased warranty exposure;
|
·
|
future competition;
|
·
|
the cyclical nature of some of our markets;
|
·
|
reduction of business with large customers;
|
·
|
risks associated with government contracts;
|
·
|
changes in the supply of, or price for, raw materials, parts and components;
|
·
|
environmental compliance costs and liabilities;
|
·
|
risks and costs associated with asbestos-related litigation;
|
·
|
potential write-offs of our substantial goodwill and other intangible assets;
|
·
|
our ability to successfully develop new products;
|
·
|
failure to protect our intellectual property;
|
·
|
the effect of, or change in, government regulations (including tax);
|
·
|
economic disruption caused by terrorist attacks, health crises or other unforeseen events; and
|
·
|
the factors discussed in other reports filed with the SEC.
|
|
|
Three months ended
June 30, |
|
Six months ended
June 30, |
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
197,543
|
|
$
|
203,944
|
|
$
|
379,782
|
|
$
|
399,080
|
|
Energy Systems & Controls
|
|
|
155,331
|
|
|
154,737
|
|
|
300,973
|
|
|
303,339
|
|
Medical & Scientific Imaging
|
|
|
207,957
|
|
|
150,921
|
|
|
408,401
|
|
|
313,732
|
|
RF Technology
|
|
|
223,179
|
|
|
215,270
|
|
|
431,989
|
|
|
419,787
|
|
Total
|
|
$
|
784,010
|
|
$
|
724,872
|
|
$
|
1,521,145
|
|
$
|
1,435,938
|
|
Gross profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
51.6
|
%
|
|
50.4
|
%
|
|
51.4
|
%
|
|
50.5
|
%
|
Energy Systems & Controls
|
|
|
56.3
|
|
|
55.7
|
|
|
55.9
|
|
|
54.9
|
|
Medical & Scientific Imaging
|
|
|
66.6
|
|
|
63.7
|
|
|
66.9
|
|
|
64.5
|
|
RF Technology
|
|
|
52.8
|
|
|
52.3
|
|
|
53.3
|
|
|
52.0
|
|
Total
|
|
|
56.8
|
|
|
54.9
|
|
|
57.0
|
|
|
54.9
|
|
Selling, general & administrative expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
26.0
|
%
|
|
20.0
|
%
|
|
24.1
|
%
|
|
20.5
|
%
|
Energy Systems & Controls
|
|
|
29.5
|
|
|
29.7
|
|
|
30.2
|
|
|
29.9
|
|
Medical & Scientific Imaging
|
|
|
43.7
|
|
|
40.1
|
|
|
40.6
|
|
|
39.3
|
|
RF Technology
|
|
|
25.6
|
|
|
25.2
|
|
|
26.1
|
|
|
26.2
|
|
Total
|
|
|
31.3
|
|
|
27.8
|
|
|
30.3
|
|
|
28.3
|
|
Segment operating profit:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
25.6
|
%
|
|
30.4
|
%
|
|
27.3
|
%
|
|
30.0
|
%
|
Energy Systems & Controls
|
|
|
26.8
|
|
|
26.0
|
|
|
25.7
|
|
|
25.0
|
|
Medical & Scientific Imaging
|
|
|
22.9
|
|
|
23.6
|
|
|
26.3
|
|
|
25.2
|
|
RF Technology
|
|
|
27.2
|
|
|
27.0
|
|
|
27.2
|
|
|
25.8
|
|
Total
|
|
|
25.6
|
|
|
27.1
|
|
|
26.7
|
|
|
26.7
|
|
Corporate administrative expenses
|
|
|
(2.6
|
)
|
|
(2.4
|
)
|
|
(2.7
|
)
|
|
(2.4
|
)
|
|
|
|
22.9
|
|
|
24.7
|
|
|
24.0
|
|
|
24.3
|
|
Interest expense
|
|
|
(2.9
|
)
|
|
(2.1
|
)
|
|
(2.8
|
)
|
|
(2.1
|
)
|
Other income/(expense)
|
|
|
0.3
|
|
|
(0.1
|
)
|
|
-
|
|
|
(0.1
|
)
|
Earnings before income taxes
|
|
|
20.4
|
|
|
22.5
|
|
|
21.2
|
|
|
22.1
|
|
Income taxes
|
|
|
(6.2
|
)
|
|
(6.7
|
)
|
|
(5.6
|
)
|
|
(6.6
|
)
|
Net earnings
|
|
|
14.2
|
%
|
|
15.8
|
%
|
|
15.5
|
%
|
|
15.5
|
%
|
|
|
Net orders booked for the
three months ended June 30, |
|
Order backlog as of June 30,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
Industrial Technology
|
|
$
|
204,506
|
|
$
|
202,120
|
|
$
|
132,911
|
|
$
|
147,917
|
|
Energy Systems & Controls
|
|
|
159,955
|
|
|
157,775
|
|
|
125,471
|
|
|
128,018
|
|
Medical & Scientific Imaging
|
|
|
210,233
|
|
|
148,386
|
|
|
250,319
|
|
|
120,329
|
|
RF Technology
|
|
|
241,817
|
|
|
255,195
|
|
|
519,787
|
|
|
486,051
|
|
|
|
$
|
816,511
|
|
$
|
763,476
|
|
$
|
1,028,488
|
|
$
|
882,315
|
|
|
Three months ended
June 30, |
Six months ended
June 30, |
||||||||||||||
|
2013
|
2012
|
2013
|
2012
|
||||||||||||
Cash provided by/(used in):
|
||||||||||||||||
Operating activities
|
$
|
139.7
|
$
|
119.3
|
$
|
311.0
|
$
|
260.8
|
||||||||
Investing activities
|
(1,014.9
|
)
|
(28.1
|
)
|
(1,028.1
|
)
|
(56.9
|
)
|
||||||||
Financing activities
|
819.7
|
(17.4
|
)
|
730.9
|
(19.6
|
)
|
$500 million senior notes due 2013*
|
$
|
500,156
|
||
$400 million senior notes due 2017
|
400,000
|
|||
$800 million senior notes due 2018
|
800,000
|
|||
$500 million senior notes due 2019
|
500,000
|
|||
$500 million senior notes due 2022
|
500,000
|
|||
Senior Subordinated Convertible Notes
|
10,121
|
|||
Revolving Facility
|
42,000
|
|||
Other
|
5,946
|
|||
Total debt
|
2,758,223
|
|||
Less current portion
|
512,799
|
|||
Long-term debt
|
$
|
2,245,424
|
|
|
June 30,
2013 |
|
|
December 31,
2012
|
|||
Total debt
|
|
$
|
2,758,223
|
|
|
$
|
2,022,122
|
|
Cash
|
|
|
(374,571
|
)
|
|
|
(370,590
|
)
|
Net debt
|
|
|
2,383,652
|
|
|
|
1,651,532
|
|
Stockholders' equity
|
|
|
3,889,548
|
|
|
|
3,687,726
|
|
Total net capital
|
|
$
|
6,273,200
|
|
|
$
|
5,339,258
|
|
|
|
|
|
|
|
|
|
|
Net debt / Total net capital
|
|
|
38.0
|
%
|
|
|
30.9
|
%
|
4.1
|
Form of 2.05% Senior Notes due 2018, incorporated herein by reference to exhibit 4.1 to the Roper Industries, Inc. Current Report on Form 8-K filed June 6, 2013.
|
|
|
|
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|
/s/ Brian D. Jellison
|
|
Chairman of the Board, President,
|
August 7, 2013
|
Brian D. Jellison
|
|
and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
/s/ John Humphrey
|
|
Chief Financial Officer and
|
August 7, 2013
|
John Humphrey
|
|
Executive Vice President
|
|
|
|
(Principal Financial Officer)
|
|
/s/ Paul J. Soni
|
|
Vice President and Controller
|
August 7, 2013
|
Paul J. Soni
|
|
(Principal Accounting Officer)
|
|
4.1
|
Form of 2.05% Senior Notes due 2018, incorporated herein by reference to Exhibit 4.1 to the Roper Industries, Inc. Current Report on Form 8-K filed June 6, 2013.
|
|
|
|
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|